Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Feb 24, 2021
Webinar - Computational Methods and High Throughput Screening in the Formulation of ASDs
Read more
Scientific Article
/ Feb 12, 2021
Webinar - From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
Read more
Scientific Article
/ Feb 02, 2022
Webinar - Process safety evaluation and scale-up resorting to mechanistic modelling for exothermic and gas releasing reactions
Read more
Scientific Article